Hydroxychloroquine (HCQ) doses of at least 400 mg/day provided better symptom relief for Taiwanese people with systemic lupus ...

The overall risk for incident retinopathy in patients who received hydroxychloroquine for 5 or more years was low but progressively increased with higher doses, according to researchers. Data derived ...

Please provide your email address to receive an email when new articles are posted on . More commonly, though, with prolonged exposure to the drug, fundus examination shows profound pigmentary changes ...

Although lower HCQ doses became part of guidelines to counter the risk for long-term HCQ-induced retinopathy and vision loss, optimal dosing should be reassessed given these new findings, say the ...

A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...

Two new papers, representing the largest number of patients studied to date, reinforce the view that the use of hydroxychloroquine and chloroquine is toxic to the heart and likely does more harm than ...

Credit: Getty Images. Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than ...

A cohort study of more than 3,000 persons who received hydroxychloroquine for 5 or more years with guideline-recommended serial retinopathy screening found that the overall risk for incident ...

NEW YORK--(BUSINESS WIRE)--Week two data of the Barometer study from 5,000 physicians in 30 countries conducted by Sermo reveals the emergence of treatment patterns. Sermo, the largest global ...

Treatment options have been limited in the ongoing coronavirus disease 2019 (COVID-19) pandemic. Earlier optimism regarding immunomodulatory drugs such as azithromycin (AZM) and hydroxychloroquine ...

President Trump and many others believe this drug has great promise for treating COVID-19. His health advisers urge against putting too much hope in the drug, which is used to treat conditions such as ...